TWEAK RECEPTOR AGONISTS AS ANTI-ANGIOGENIC AGENTS BACKGROUND
摘要
The present invention relates to methods of modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists. In particular, methods for inhibiting angiogenesis are disclosed.